Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | carboxyl transferase domain-containing protein | 0.1134 | 0.9595 | 1 |
Trypanosoma brucei | acetyl-CoA carboxylase | 0.1175 | 1 | 1 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.0448 | 0.2839 | 0.2839 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0333 | 0.1712 | 1 |
Chlamydia trachomatis | biotin carboxylase | 0.0406 | 0.2433 | 1 |
Toxoplasma gondii | pyruvate carboxylase | 0.0448 | 0.2839 | 0.2839 |
Loa Loa (eye worm) | AUR protein kinase | 0.0333 | 0.1712 | 0.1732 |
Trypanosoma cruzi | aurora B kinase, putative | 0.0333 | 0.1712 | 0.306 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0333 | 0.1712 | 1 |
Leishmania major | protein kinase, putative | 0.0333 | 0.1712 | 0.1712 |
Trypanosoma cruzi | acetyl-CoA carboxylase | 0.0727 | 0.5594 | 1 |
Loa Loa (eye worm) | AUR protein kinase | 0.0333 | 0.1712 | 0.1732 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain, AccA2 | 0.0448 | 0.2839 | 1 |
Giardia lamblia | Aurora kinase | 0.0333 | 0.1712 | 1 |
Plasmodium falciparum | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.085 | 0.6803 | 1 |
Brugia malayi | serine/threonine protein kinase 6 | 0.0333 | 0.1712 | 0.1732 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.0448 | 0.2839 | 0.5074 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0333 | 0.1712 | 0.1712 |
Trypanosoma brucei | aurora B kinase | 0.0333 | 0.1712 | 0.1712 |
Toxoplasma gondii | acetyl-CoA carboxylase ACC1 | 0.1175 | 1 | 1 |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0333 | 0.1712 | 1 |
Toxoplasma gondii | aurora kinase | 0.0333 | 0.1712 | 0.1712 |
Toxoplasma gondii | AGC kinase | 0.0165 | 0.0061 | 0.0061 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0333 | 0.1712 | 0.1732 |
Mycobacterium ulcerans | bifunctional protein acetyl-/propionyl-coenzyme a carboxylase (alpha chain) AccA3 | 0.0448 | 0.2839 | 1 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.0448 | 0.2839 | 0.5074 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0333 | 0.1712 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0333 | 0.1712 | 1 |
Brugia malayi | serine/threonine kinase 12 | 0.0333 | 0.1712 | 0.1732 |
Mycobacterium ulcerans | pyruvate carboxylase | 0.0448 | 0.2839 | 1 |
Wolbachia endosymbiont of Brugia malayi | Acetyl/propionyl-CoA carboxylase, alpha subunit | 0.0448 | 0.2839 | 1 |
Toxoplasma gondii | acetyl-coA carboxylase ACC2 | 0.1175 | 1 | 1 |
Echinococcus multilocularis | acetyl coenzyme A carboxylase 1 | 0.1175 | 1 | 1 |
Entamoeba histolytica | protein kinase , putative | 0.0333 | 0.1712 | 1 |
Schistosoma mansoni | acetyl-CoA carboxylase | 0.1175 | 1 | 1 |
Entamoeba histolytica | acetyl-coA carboxylase, putative | 0.02 | 0.0405 | 0.2087 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.0448 | 0.2839 | 0.2839 |
Plasmodium vivax | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.085 | 0.6803 | 1 |
Echinococcus multilocularis | aurora kinase A | 0.0333 | 0.1712 | 0.1712 |
Loa Loa (eye worm) | AUR protein kinase | 0.0333 | 0.1712 | 0.1732 |
Echinococcus granulosus | propionyl coenzyme A carboxylase alpha chain | 0.0448 | 0.2839 | 0.2839 |
Entamoeba histolytica | protein kinase, putative | 0.0333 | 0.1712 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0333 | 0.1712 | 1 |
Echinococcus granulosus | aurora kinase A | 0.0333 | 0.1712 | 0.1712 |
Echinococcus granulosus | serine:threonine protein kinase 12 B | 0.0333 | 0.1712 | 0.1712 |
Mycobacterium ulcerans | acetyl-/propionyl-coenzyme a carboxylase alpha chain AccA1 | 0.0448 | 0.2839 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0333 | 0.1712 | 1 |
Schistosoma mansoni | pyruvate carboxylase | 0.0448 | 0.2839 | 0.2839 |
Mycobacterium tuberculosis | Probable acetyl-/propionyl-coenzyme A carboxylase alpha chain (alpha subunit) AccA2: biotin carboxylase + biotin carboxyl carrie | 0.0448 | 0.2839 | 1 |
Leishmania major | carboxylase, putative | 0.0448 | 0.2839 | 0.2839 |
Trichomonas vaginalis | AGC family protein kinase | 0.0333 | 0.1712 | 1 |
Echinococcus multilocularis | propionyl coenzyme A carboxylase alpha chain | 0.0448 | 0.2839 | 0.2839 |
Echinococcus multilocularis | serine:threonine protein kinase 12 B | 0.0333 | 0.1712 | 0.1712 |
Brugia malayi | Carboxyl transferase domain containing protein | 0.1134 | 0.9595 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0333 | 0.1712 | 1 |
Mycobacterium tuberculosis | Probable pyruvate carboxylase Pca (pyruvic carboxylase) | 0.0448 | 0.2839 | 1 |
Schistosoma mansoni | protein kinase | 0.0333 | 0.1712 | 0.1712 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0448 | 0.2839 | 0.2839 |
Leishmania major | methylcrotonoyl-coa carboxylase biotinylated subunitprotein-like protein | 0.0448 | 0.2839 | 0.2839 |
Trypanosoma brucei | unspecified product | 0.0294 | 0.1329 | 0.1329 |
Leishmania major | acetyl-CoA carboxylase, putative | 0.1175 | 1 | 1 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0165 | 0.0061 | 0.0061 |
Mycobacterium leprae | Probable bifunctional protein acetyl-/propionyl-coenzyme A carboxylase, alpha chain AccA3 (BccP) | 0.0448 | 0.2839 | 1 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0448 | 0.2839 | 0.2839 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.